PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7948386-0	1994	Effects of oral administration of bezafibrate on peroxisomes and carnitine acetyltransferase in rat hepatocytes.	Bezafibrate	34-45	carnitine O-acetyltransferase	Rattus norvegicus	65-92	
7948386-5	1994	Activity of carnitine acetyltransferase (CAT), one of the enzymes involved in beta oxidation of fatty acids, increased significantly after oral administration of bezafibrate.	Bezafibrate	162-173	carnitine O-acetyltransferase	Rattus norvegicus	12-39	
7948386-5	1994	Activity of carnitine acetyltransferase (CAT), one of the enzymes involved in beta oxidation of fatty acids, increased significantly after oral administration of bezafibrate.	Bezafibrate	162-173	carnitine O-acetyltransferase	Rattus norvegicus	41-44	
7948386-8	1994	CAT activity was also detected in the matrix of peroxisomes at two weeks after oral administration of bezafibrate.	Bezafibrate	102-113	carnitine O-acetyltransferase	Rattus norvegicus	0-3	
8075222-8	1994	In the experimental administration of bezafibrate, a hypolipidemic drug increasing the CAT activity, the CAT activity in the brown adipose tissue was significantly increased (male 6.0-fold, female 2.0-fold) at two weeks of administration of bezafibrate except for castrated male and female rats.	Bezafibrate	38-49	carnitine O-acetyltransferase	Rattus norvegicus	87-90	
8075222-8	1994	In the experimental administration of bezafibrate, a hypolipidemic drug increasing the CAT activity, the CAT activity in the brown adipose tissue was significantly increased (male 6.0-fold, female 2.0-fold) at two weeks of administration of bezafibrate except for castrated male and female rats.	Bezafibrate	38-49	carnitine O-acetyltransferase	Rattus norvegicus	105-108	
8075222-8	1994	In the experimental administration of bezafibrate, a hypolipidemic drug increasing the CAT activity, the CAT activity in the brown adipose tissue was significantly increased (male 6.0-fold, female 2.0-fold) at two weeks of administration of bezafibrate except for castrated male and female rats.	Bezafibrate	241-252	carnitine O-acetyltransferase	Rattus norvegicus	105-108	
3048253-3	1988	Rat hepatocytes cultured with bezafibrate or ciprofibrate (0.1-10 micrograms/ml) for 48 h had increased activities of carnitine acetyltransferase (CAT; 4-6-fold) and carnitine palmitoyltransferase (CPT; 12-34%).	Bezafibrate	30-41	carnitine O-acetyltransferase	Rattus norvegicus	118-145	
3048253-3	1988	Rat hepatocytes cultured with bezafibrate or ciprofibrate (0.1-10 micrograms/ml) for 48 h had increased activities of carnitine acetyltransferase (CAT; 4-6-fold) and carnitine palmitoyltransferase (CPT; 12-34%).	Bezafibrate	30-41	carnitine O-acetyltransferase	Rattus norvegicus	147-150	
3421940-3	1988	When hepatocytes were cultured with etomoxir and benzafibrate (a hypolipidaemic analogue of clofibrate) for 48 h, etomoxir prevented the 5-fold increase in CAT activity caused by bezafibrate, whereas bezafibrate suppressed the increase in glucose-6-phosphate dehydrogenase and fructose-bisphosphatase caused by etomoxir.	Bezafibrate	179-190	carnitine O-acetyltransferase	Rattus norvegicus	156-159	
3421940-3	1988	When hepatocytes were cultured with etomoxir and benzafibrate (a hypolipidaemic analogue of clofibrate) for 48 h, etomoxir prevented the 5-fold increase in CAT activity caused by bezafibrate, whereas bezafibrate suppressed the increase in glucose-6-phosphate dehydrogenase and fructose-bisphosphatase caused by etomoxir.	Bezafibrate	200-211	carnitine O-acetyltransferase	Rattus norvegicus	156-159	
1610295-2	1992	In both strains, bezafibrate effectively reduced serum and hepatic lipids, increased the liver weight, induced a proliferation of peroxisomes, and selectively elevated the activities of carnitine acetyltransferase and of the enzymes of the peroxisomal beta-oxidation system.	Bezafibrate	17-28	carnitine O-acetyltransferase	Rattus norvegicus	186-213